PFD closes $15.4 million medical receivables offering

7 hours ago
By AI, Created 20:16 UTC, Nov 20, 2026, AGP -

PFD Capital Partners said it closed a securities offering for PFDSelect Medical Receivables 1022, LLC with $15.4 million in subscriptions. The deal adds capital to PFD's financing platform for medical providers treating personal injury patients.

Why it matters: - The closing gives PFD Capital Partners more capital to fund medical receivables tied to personal injury cases. - The financing model helps medical providers access cash before claims are resolved, which can ease working-capital pressure. - The offering adds to a larger specialty-finance platform that has already funded billions of dollars in billed receivables.

What happened: - PFD Capital Partners said it closed the securities offering for PFDSelect Medical Receivables 1022, LLC to new investors. - Subscriptions totaled $15,396,533. - The company announced the closing on November 20, 2026. - PFD says the offering was conducted under Rule 506(c) of Regulation D.

The details: - PFD's platform provides capital solutions to U.S. medical service providers that treat patients injured in personal injury cases. - The financing model lets providers obtain capital against qualifying receivables instead of waiting for payment after claims resolve. - Affiliated PFD companies handle underwriting, documentation, portfolio administration, servicing and collections. - As of March 31, 2026, PFD reported cumulative financing activity of about $2.19 billion in billed medical receivables. - About $1.57 billion of those receivables remained outstanding as of that date. - PFD said the platform had advanced about $389 million in capital to finance medical receivables. - PFD said those figures reflect historical financing activity and are separate from the Fund 1022 proceeds.

Between the lines: - The raise suggests continued investor interest in specialty finance linked to healthcare receivables. - The company is positioning the platform as a recurring source of liquidity for providers rather than a one-time transaction. - PFD also included risk language that highlighted collection delays, reduced recoveries, illiquidity and possible loss of invested capital.

What's next: - PFD Capital Partners is likely to keep using the platform to originate and finance additional medical receivables. - Future results will depend on collections, claim resolution timing and broader credit conditions. - The company did not announce any new target size or follow-on offering in this release.

The bottom line: - PFD closed another funding round for its medical receivables business, reinforcing a financing model built around cash flow to personal-injury medical providers.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Finance Industry Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Finance Industry Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.